Mobile reminders to improve eye drop use and eye pressure in glaucoma
Part of Eyes & vision clinical trials.
This trial tests whether personalized reminders sent to your phone help you remember to use your glaucoma eye drops regularly, which may improve your eye pressure control. If you join, you'll receive reminders and have your eye pressure checked over 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have primary open-angle glaucoma in at least one eye.
- You are currently using at least one glaucoma eye drop or medication.
- You have a mobile phone that can receive text messages or WhatsApp messages.
- You are willing to attend follow-up visits and follow study procedures for 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop against an existing one to see which better lowers eye pressure in people with open-angle glaucoma or ocular hypertension. You may be able to join if you have high eye pressure in both eyes that needs treatment and you are at least 18 years old.
This trial tests an investigational drug called REGN22530 for people with mild to moderate primary open-angle glaucoma or ocular hypertension (high eye pressure). The goal is to see if it can safely lower eye pressure and protect vision.
This study tests whether measuring your eye pressure at home with a special device can help control glaucoma and slow its progression. It may offer a more convenient way to track your condition between doctor visits.
This study tests a program to help people with glaucoma take their eye drops regularly and keep their eye appointments. If you've had trouble sticking to your eye drop schedule or missed appointments, this trial may offer support to protect your vision.
This trial tests whether a special cap called iD2 helps people remember to take their glaucoma eye drops on time. If you've struggled to keep up with your eye drops, this may help you build a better routine.
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
Hear when a new Primary Open-Angle Glaucoma (POAG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.